GNCA insider filings

GENOCEA BIOSCIENCES, INC. — 49 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-06-03. Screen GNCA transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for GNCA between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — GENOCEA BIOSCIENCES, INC.

FiledFormInsiderReported transactionsSource
2022-06-034Duvall Diantha — CHIEF FINANCIAL OFFICERSale (S): 1,355 @ $0.06EDGAR
2022-06-034Flechtner Jessica Baker — Chief Scientific OfficerSale (S): 1,578 @ $0.06EDGAR
2022-06-034Clark William D — President and CEO, DirectorSale (S): 4,023 @ $0.06EDGAR
2022-06-024SUMER JACQUELYN L — CHIEF LEGAL & COMPLIANCE OFFSale (S): 2,500 @ $0.06EDGAR
2022-06-024Clark William D — President and CEO, DirectorSale (S): 117,244 @ $0.06EDGAR
2022-06-014Siber George — DirectorSale (S): 20,425 @ $0.07EDGAR
2022-05-264STAPLETON RAYMOND D JR — CHIEF TECHNOLOGY OFFICERSale (S): 2,500 @ $0.09EDGAR
2022-05-264Flechtner Jessica Baker — Chief Scientific OfficerSale (S): 16,525 @ $0.09EDGAR
2022-05-264Duvall Diantha — CHIEF FINANCIAL OFFICERSale (S): 24,407 @ $0.08EDGAR
2022-05-264Walker Paul Edward — 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264Sonsini Peter W. — 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264New Enterprise Associates 16, L.P. — 10% owner
NEA Partners 16, L.P. — 10% owner
NEA 16 GP, LLC — 10% owner
Sale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264Makhzoumi Mohamad — 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264Florence Anthony A. Jr. — 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264Chang Carmen — 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264Behbahani Ali — Director, 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264BASKETT FOREST — 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-05-264SANDELL SCOTT D — 10% ownerSale (S): 5,931,843 @ $0.07 · Sale (S): 4,445,093 @ $0.08EDGAR
2022-04-054Flechtner Jessica Baker — Chief Scientific OfficerSale (S): 1,212 @ $1.25EDGAR
2022-04-054Duvall Diantha — CHIEF FINANCIAL OFFICERSale (S): 963 @ $1.25EDGAR
2022-04-054Aakalu Girish N — CHIEF BUSINESS OFFICERSale (S): 963 @ $1.25EDGAR
2022-04-054Clark William D — President and CEO, DirectorSale (S): 3,924 @ $1.25EDGAR
2022-04-054Davis Thomas Andrew — CHIEF MEDICAL OFFICERSale (S): 1,091 @ $1.25EDGAR
2022-03-174SUMER JACQUELYN L — CHIEF LEGAL & COMPLIANCE OFFGrant/award (A): 37,500 @ $0 · Grant/award (A): 112,500 (derivative) @ $0EDGAR
2022-03-174STAPLETON RAYMOND D JR — CHIEF TECHNOLOGY OFFICERGrant/award (A): 43,750 @ $0 · Grant/award (A): 131,250 (derivative) @ $0EDGAR
2022-03-174Flechtner Jessica Baker — Chief Scientific OfficerGrant/award (A): 43,750 @ $0 · Sale (S): 3,349 @ $1.10 · Grant/award (A): 131,250 (derivative) @ $0EDGAR
2022-03-174Duvall Diantha — CHIEF FINANCIAL OFFICERGrant/award (A): 37,500 @ $0 · Sale (S): 2,873 @ $1.10 · Grant/award (A): 112,500 (derivative) @ $0EDGAR
2022-03-174Aakalu Girish N — CHIEF BUSINESS OFFICERGrant/award (A): 31,250 @ $0 · Sale (S): 2,397 @ $1.10 · Grant/award (A): 93,750 (derivative) @ $0EDGAR
2022-03-174Clark William D — President and CEO, DirectorGrant/award (A): 150,000 @ $0 · Sale (S): 11,435 @ $1.10 · Grant/award (A): 450,000 (derivative) @ $0EDGAR
2022-03-174Davis Thomas Andrew — CHIEF MEDICAL OFFICERGrant/award (A): 31,250 @ $0 · Sale (S): 2,717 @ $1.10 · Grant/award (A): 93,750 (derivative) @ $0EDGAR
2022-03-074Lunger John — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2021-09-284Herron Jennifer Lyn — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2021-07-024Siber George — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-024Bosley Katrine — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-024Higgins Michael J — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-024Behbahani Ali — Director, 10% ownerGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-024Schwab Gisela — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-024BATE KENNETH — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2021-03-174Duvall Diantha — CHIEF FINANCIAL OFFICERGrant/award (A): 37,500 @ $0 · Grant/award (A): 112,500 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-03-174Flechtner Jessica Baker — Chief Scientific OfficerGrant/award (A): 43,750 @ $0 · Grant/award (A): 131,250 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-03-174Aakalu Girish N — CHIEF BUSINESS OFFICERGrant/award (A): 31,250 @ $0 · Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-03-174SUMER JACQUELYN L — CHIEF LEGAL & COMPLIANCE OFFGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-03-174STAPLETON RAYMOND D JR — EVP PHARM SCI & MFGGrant/award (A): 100,000 (derivative) @ $0EDGAR
2021-03-174Clark William D — President and CEO, DirectorGrant/award (A): 150,000 @ $0 · Grant/award (A): 450,000 (derivative) @ $0 · Grant/award (A): 600,000 (derivative) @ $0EDGAR
2021-03-174Davis Thomas Andrew — CHIEF MEDICAL OFFICERGrant/award (A): 31,250 @ $0 · Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2021-03-024SUMER JACQUELYN L — CHIEF LEGAL & COMPLIANCE OFFGrant/award (A): 115,000 (derivative) @ $3.07EDGAR
2021-02-184Clark William D — President and CEO, DirectorOption exercise (M): 16,500 @ $1.66 · Option exercise (M): 19,998 @ $2.72 · Option exercise (M): 19,998 (derivative) @ $0 · Option exercise (M): 16,500 (derivative) @ $0EDGAR
2021-02-014STAPLETON RAYMOND D JR — EVP PHARM SCI & MFGGrant/award (A): 125,000 (derivative) @ $0EDGAR
2020-11-104Clark William D — President and CEO, DirectorPurchase (P): 4,760 @ $2.06EDGAR

Recent 8-K events — GENOCEA BIOSCIENCES, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-06-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-248-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-04-288-K?
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-078-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2022-01-048-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2021-10-288-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-09-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2021-07-298-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-07-138-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=GNCA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs